ReviewFrontiers in psychology2025
Cancer as trauma: multidimensional determinants of PTSD across the disease course. A narrative integrative review.
Review in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-traumatic stress disorder (PTSD) is a significant psychological response of cancer diagnosis, treatment, and survivorship. This review synthesizes evidence on the psychological, socioemotional, and biomedical determinants of cancer-related PTSD, emphasizing how these factors interact across the disease trajectory. Methods: We conducted a narrative integrative review of PubMed, PsycINFO, and Scopus. Eligible studies included articles published between 2015 and March 2025 reporting adults with cancer assessed for PTSD using validated instruments across different study designs. Based on findings on prevalence, predictors, and assessment tools a biopsychosocial model was structured. Results: Twenty-three studies met inclusion criteria, mainly from the United States and China, with breast cancer as the most frequently studied diagnosis. Reported PTSD prevalence ranged widely, from 0 to 72.5%, depending on the instruments and cutoffs used. Psychological determinants included affective comorbidities, fear of recurrence, maladaptive coping, and prior psychiatric history. Socioemotional determinants involved social support, communication quality, demographic variables, and cultural factors. Medical-biological determinants related to treatment aggressiveness, symptom burden, disease stage, and inflammation. Younger age, female sex, and limited social support consistently elevated risk. PTSD was associated with lower quality of life, reduced adherence to treatment, and poorer survivorship outcomes. Conclusion: Cancer-related PTSD reflects the continuous interaction of psychological, socio-emotional, and medical-biological factors across the cancer journey. These findings underscore the need for culturally sensitive assessment tools and for adapting interventions to the specific demands of each phase of care. Increasing trauma-informed awareness among multidisciplinary teams can enhance early identification of at-risk patients and support patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.